The regulation of hippocampal nicotinic acetylcholine receptors (nAChRs) after a protracted treatment with selective or nonselective nAChR agonists

Journal of Molecular Neuroscience

Volumn 13, Issue 1-2, 1999, Pages 31-45

  Auta, James ^a   Longone, Patrizia ^a   Guidotti, Alessandro ^a   Costa, Erminio ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Hippocampus; NAChR; NAChr agonists; Nicotine; Protein expression

Indexed keywords

ALPHA BUNGAROTOXIN; EPIBATIDINE; IODINE 125; LOBELINE; MESSENGER RNA; METHYLLYCACONITINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS; RODENTIA; TRITIUM;

EID: 0033368620     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/jmn:13:1-2:31     Document Type: Article

References (49)

1. Albuquerque E. X., Alkondon M., Pereira E., Castro G. N., Schrattenholz A., Barbosa C. T. F., et al. (1996) Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J. Pharmacol. Exp. Ther. 280, 1117-1136.
2. Banerjee S. and Abood L. J. (1989) Nicotine antagonists: Phosphoinositide turn-over and receptor binding to determine muscarinic properties. Med. Pharmacol. 38(17), 261-267.
3. 3H] nicotine binding sites in human brain. J. Neurochem. 50, 1243-1247.
4. Bhat R. V., Turner S. L., Selvaag S. R., Marks M. J., and Collins A. C. (1991) Regulation of brain nicotinic receptors by chronic infusion. J Neurochem. 56(6), 1932-1939.
5. Bickford-Wimer P.C., Nagamoto H., Johnson R., Adler L., Egan M., Rose G. M., et al. (1990) Auditory sensory gating in hippocampal neurons: a model system in the rat. Biol. Psychol. 27, 183-192.
6. Bradford M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
7. 125I]-α-Bungarotoxin binding in human postmortem brain. J. Comp. Neurol. Oct 27; 387(3), 385-398.
8. Brioni J. D., Decker M. W., Sullivan J. P., and Arneric S. P. (1997) The pharmacology of (-)-nicotine and novel cholinergic channel modulators. Adv. Pharmacol. 37, 153-211.
9. 3H-nicotine in the mouse brain. Life Sci. 44, 1123-1132.
10. Changeux J. P. (1989) Functional architecture and dynamics of the nicotinic acetylcholine receptor: an allosteric ligand-gated ion channel, in: Fidia Research foundation Award Lectures, vol. 4, Raven, NY, pp. 21-168.
11. Cohen J. B., Weber M., and Changeux J. P. (1974) Effects of local anesthetics and calcium on the interaction of cholinergic ligands with the nicotinic receptor protein in Torpedo marmorata. Mol. Pharmacol. 10, 904-932.
12. Damaj M. I., Patrick G. S., Creasy K. R., and Martin B. R. (1997) Pharmacology of Lobeline, a nicotinic receptor ligand. J. Pharmacol. Exp. Ther. 282, 410-419.
13. Decker M. W., Majchzark M. J., and Arneric S. P. (1993) Effects of Lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol. Biochem. Behav. 45, 571-576.
14. Decker M. W., Brioni J. D., Bannon A. W., and Arneric S. P. (1995) Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implication for CNS therapeutics. Life Sci. 56(8), 545-570.
15. Freedman R., Hall M., Adler L. E., and Leonard S. (1995) Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychol. 38 22-33.
16. Gallo V., Upson L. M., Hayes W. P., Vyklicky L. Jr., Winters C., and Buonanno A. (1992) Molecular cloning and developmental analyses of a new glutamate receptor subunit isoform in cerebellum. J. Neurosci. 12, 1010-1023.
17. + and cAMP. Mol. Pharmacol. 34, 549-556.
18. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., et al. (1995) Comparative pharmacology of epibatidine: A potent agonist of neuronal nicotine acetylcholine receptors. Mol. Pharmacol. 48, 774-782.
19. Goldberg S. R., Risner M. E., Stolerman I. P., Reavill C., and Garcha H. S. (1989) Nicotinic and some related compounds: effects on schedule-controlled behavior and discriminative properties in rats. Psychopharmacology 97, 295-302.
20. 7 nicotinic acetylcholine receptor. Eur. J. Pharmacol. Mol. Pharmacol. 290, 237-246.
21. A receptor subunit messenger RNA by competitive polymerase chain reaction. Methods Neurosci. 12, 191-208.
22. Hollman M. and Heinemann S. (1994) Cloned glutamate receptors. Ann. Rev. Neurosci. 17 31-108.
23. Lecca D., Shim I., Costa E., and Javaid J. I. (1999) Striatal application of nicotine, but not lobeline attenuates dopamine release. Neuropharmacology (in press).
24. 3H]5-HT from rat hippocampal slices. Neuropharmacology 35(12), 1769-1777.
25. Leonard S., Adams C., Breese C. R., Adler L. E., Bickford P., Byerley W., et al. (1996) Nicotinic receptor function in schizophrenia. Schizophrenia Bull. 22, 431-445.
26. Lindstrom J. (1996) Neuronal nicotinic acetylcholine receptors. Ion Channels 4, 377-449.
27. Marks M. J., Burch J. B., and Collins A. C. (1983) Effects of chronic nicotine infusion on tolerance development and nicotine receptors. J. Pharmacol. Exp. Ther. 226, 817-825.
28. Marks M. J., Stitzel J. A., and Collins A. C. (1985) Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J. Pharmacol. Exp. Ther. 235(3), 619-628.
29. Marks M. J., Stitzel J. A., Romm E., Wehner J. M., and Collins A. C. (1986) Nicotinic binding sites in rat and mouse brain. Comparison of acetylcholine, nicotine and alpha-Bungarotoxin. Mol. Pharmacol. 30, 427-436.
30. Marks M. J., Pauly J., Gross D., Deneris E., Hermans-Borgmeyer I., Heinemann S., et al. (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci. 12, 2765-2784.
31. McLane K. E., Wu X., Lindstrom J. M., and Conti-Tronconi B. M. (1992) Epitope mapping of polyclonal and monoclonal antibodies against two α-bungarotoxin binding α-subunits from neuronal nicotinic receptors. J. Neuroimmunol. 38, 115-128.
32. McPherson G. I. (1987) Ligand (release 2.0), Elsevier Biosoft, Cambridge.
33. Messing A. (1982) Cholinergic agonist-induced down-regulation of neuronal (-bungarotoxin. Brain Res. 232, 479-484.
34. Nicoletti E, Wroblewski J. T., Novelli A., Alho H., Guidotti A., and Costa E. (1986) The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells. J. Neurosci. 6, 1905-1911.
35. 7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotine currents. J. Neurosci. 17, 9165-9171.
36. Peng X., Gerzanich V., Anand R., Wang F., and Lindstrom J. (1997) Chronic nicotine treatment up-regulates α3 and α7 acetylcholine receptor subtypes expressed by human neuroblastoma cell line SH-SY5Y. Mol Pharmacol 51, 776-784.
37. Perry D. C., Davila-Garca M. I., Musachio J. L., and Kellar K. J. (1997) Epibatidine analogs label subpopulation of neuronal nicotinic receptors. Soc. Neurosci. Abstracts 1, 154. 12.
38. Rao T. S., Correa L. D., and Lloyd G. K. (1997) Effects of lobeline and DMPP on NMDA-evoked acetylcholine release in vitro: Evidence for lack of involvement of classical neuronal nicotinic acetylcholine receptors. Neuropharmacology 36(1), 39-50.
39. 3H](-)-nicotine to rat brain membranes and its inhibition by analogs of nicotine. Neuropharmacology 27, 235-241.
40. Rollins Y. D., Stevens K. E., Harris K. R., Hall M. E., Rose G. M., and Leornard S. (1993) Reduction in auditory gating following intracerebroventricular application of α-bungaratoxin binding site ligands and α7 antisense oligonucleotide. Soc. Neurosci. Abstracts 19, 837.
41. Rowell P. P. and Li M. (1997) Dose-response relationship for nicotine-induced up-regulation of rat brain nicotine receptors. J. Neurochem. 68, 1982-1989.
42. Schwartz R. and Kellar K. (1983) Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220, 214-216.
43. 3H] dopamine uptake. J. Pharmacol. Exp. Ther. 280, 1432-1444.
44. Toro E. D., Juiz J. M., Peng X., Lindstrom J., and Criado M. (1994) Immunocytochemical localization of the α7 subunit of nicotinic acetylcholine receptor in rat central nervous system. J Comp. Neurol. 349, 325-342.
45. 3H]-epibatidine binding sites. Neuropharmacology 36(8), 1119-1125.
46. Warpman U., Friberg L., Gillespie A., Hellstrom-Lindahl E., Zhang X., and Nordberg A. (1998) Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and Sh-SY5Y neuroblastoma cells. J. Neurochem. 70(5), 2028-2037.
47. Weber M., David-Pfeuty M. T., and Changeux J. P. (1975) Regulation of binding properties of the nicotinic receptor protein by cholinergic ligands in membrane fragments from Torpedor mamorata. Proc. Natl. Acad. Sci. USA 72, 3443-3447.
48. Wonnacott S. (1990) The paradox of nicotine acetylcholine receptor up-regulation by nicotine. Trends Pharmacol. Sci. 11, 216-219.
49. 2-mutant mice. J. Neurosci. 18, 4461-4472.